After five years of treatment, Taltz significantly cleared skin in 94.3% of moderate-to-severe plaque psoriasis patients and maintained totally clear skin in 46.6% of patients, according to data presented Tuesday at the World Congress of Dermatology meeting in Milan, Italy. Lilly said the five-year data did not turn up any new side effects in the 110 patients who participated in the study.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,